Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Completed × saracatinib × Clear all

Phase

Phase 2 8 Phase 1 3 Phase 1/2 2 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1 Fallopian Tube Neoplasms 1

Interventions

Fluorouracil 21 Cisplatin 20 Gemcitabine 15 Radiotherapy 14 Oxaliplatin 14 Paclitaxel 13 Docetaxel 13 Carboplatin 12 Capecitabine 12 Bevacizumab 12 Leucovorin 11 Cyclophosphamide 11 Irinotecan 10 Drug Therapy 10 Cytarabine 9 Magnetic Resonance Spectroscopy 7 Dexamethasone 7 Saline Solution 6 Rituximab 6 Nivolumab 6 Methotrexate 6 Letrozole 6 Exercise 6 Etoposide 6 pembrolizumab 5 Melphalan 5 Lidocaine 5 Filgrastim 5 Electroporation 5 Doxorubicin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01196741 2015-05-05

SaPPrOC

University College, London

Phase 2/3 Completed

107 enrolled 17 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡